Publication & Citation Trends
Publications
0 total
TRASTUZUMAB TREATMENT OF EARLY STAGE BREAST CANCER IS COST-EFFECTIVE FROM THE PERSPECTIVE OF THE BELGIAN HEALTH CARE AUTHORITIES
Cited by 30
Semantic Scholar
PCN44 ADJUVANTTRASTUZUMAB TREATMENT IN EARLY STAGE BREAST CANCER: COST-EFFECTIVENESS IN THE BELGIAN HEALTH CARE SETTING OA
Cited by 1
Semantic Scholar
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels.
Cited by 14
Semantic Scholar
A health economic model to assess the cost‐effectiveness of PEG IFN α‐2a and ribavirin in patients with mild chronic hepatitis C
Cited by 14
Semantic Scholar
A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients.
Cited by 23
Semantic Scholar
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. OA
Cited by 63
Semantic Scholar
Research Topics
Hepatitis C virus research
(3)
Pharmacology and Obesity Treatment
(3)
Systemic Lupus Erythematosus Research
(2)
Liver Disease Diagnosis and Treatment
(2)
HER2/EGFR in Cancer Research
(2)
Affiliations
Roche (Switzerland)
Roche (Belgium)
La Roche College